🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌷 EASL Pre-Congress Event: Consensus Conference on PBC This year, deepen your expertise with a unique pre-congress event exploring surrogate endpoints and real-world evidence in Primary Biliary Cholangitis (PBC). 🔬 What to expect: Gain insights into how real-world evidence

🌟 What’s it about? Biliary abnormalities in autoimmune hepatitis (AIH) and interface hepatitis in primary biliary cholangitis (PBC) can often be misinterpreted, leading to therapeutic mistakes that negatively impact patients.

🌷We are gearing up for #EASLCongress on 7-10 May! 🔥 Early registration ends in one week! Secure your spot by 14 January 2025 and enjoy reduced rates. easlcongress.eu/2025-registrat… ✨ Pre-congress events: Start your experience early on 6 May with two exclusive sessions to deepen

In press on CGH our multicenter study 🇮🇹 🇬🇧 on 293 pts with PBC 🔥 Non-invasive tests for portal hypertension perform poorly when cholestasis is severe. 👊RESIST criteria (PLT+albumin) outperform stiffness-based criteria Vincenza Calvaruso Marco Carbone cghjournal.org/article/S1542-…

Available and emerging therapies for primary biliary cholangitis (PBC): Get expert insights in three new streaming episodes. #PeerVoice #meded #gastroenterology #hepatology #hepaticdisorders #biliarydisorders peervoice.com/BYM?PromoCode=…

🙏Many thanks @pscpartners & PSC Partners Canada 🍀😅 😊The important ones: 👉Biogipuzkoa team (ainhoa Pedro Rodrigues adelaidalacasta Luis Bujanda Matxus Perugorria et al) 👉Good international cols (Tom Hemming Karlsen Marco Carbone Lewis Roberts et al), & 👉Patients

🔔 La presentazione del Libro Bianco AISF si può seguire anche in diretta streaming 💻 al link buff.ly/418JK5r #fegato #AISF #malattieepatiche

I temi scientifici con i Prof. Alessio Aghemo, Salvatore Petta, Luca Valenti, Marco Carbone, GIUSEPPE CABIBBO, Quirino Lai. Epatiti Virali, Steatosi, Epatopatia Alcolica, Malattie Rare, Autoimmuni e Colestatiche, Cirrosi, Epatocarcinoma, Trapianto di Fegato. #LibroBiancoAISF

Autoimmune Liver Disease Days. Italian Autoimmune Liver Disease Clinical Research Network (IT-AILD CRN). #itaild #liver AISF - Associazione Italiana Studio Fegato

In today's #readoftheweek📚 learn about the ALNE model and how it generates quantitative and accurate differential diagnosis between cases with AIH or PBC. Read here this JHEP Reports article: jhep-reports.eu/article/S2589-… 🙏Alessio Gerussi @BastianEngel Laura Cristoferi federica malinverno

Best practices in tracking treatment response and targeting contemporary goals of care for patients with primary biliary cholangitis (PBC): Get expert insights in seven new streaming episodes. #PeerVoice #meded #hepatology #gastroenterology peervoice.com/DNW?PromoCode=…

Il Dott. Marco Carbone ospite di Terzo Millennio Salute su Gold TV intervistato da Daniel Della Seta ha spiegato quali sono le priorità in tema di #malattierare e #malattieautoimmuni del fegato. Dal min. 13.40 youtube.com/watch?v=Na2GsV…

Ospedale Niguarda di Milano è il miglior ospedale italiano riconosciuto anche a livello mondiale, secondo la classifica di Newsweek ⤵️ ospedaleniguarda.it/news/leggi/osp…

EASLnews Marco Carbone Emma Culver Lindsey Kennedy PBC Foundation Ana Lleo Verena Keitel-Anselmino Jesus Bañales Sven Francque Journal of Hepatology #AIH or #DILI? A steroid trial can help guide the diagnosis. 👉But remission in AIH isn’t just biochemical. Clinical and histological remission matter too! 👉Patients in biochemical remission show better long-term outcomes. EASLnews #EASLcongress

EASLnews Marco Carbone Emma Culver Lindsey Kennedy PBC Foundation Ana Lleo Verena Keitel-Anselmino Jesus Bañales Sven Francque Journal of Hepatology Yujun_Wong Dr.Bornie Who's ready for #AIH immunosuppression withdrawal? ✔️ Stable remission on monotherapy (≥2 yrs) 🧪 ALT & IgG levels at withdrawal matter 📉 Lower ALT/IgG = better odds of remission 🧠 MRI cT1 adds insight beyond biochemistry @EASLNews #EASLCongress

EASLnews 🧪 PSC diagnosis and monitoring challenges ALP is widely used but has also a broad variation across patients. 👉🏽 ELF test and elastography are promising tools for prognosis - highlighted in the EASL CPGs on PSC: journal-of-hepatology.eu/article/S0168-… @EASLNews Marco Carbone Emma Culver

EASLnews Marco Carbone Emma Culver 🧲 MRI in PSC management Beyond standard MRI, tools like MRE, Anali score, MRCP+, and DiStrict score help assess fibrosis and disease activity with more precision. 🤝 Close collaboration between hepatology and radiology is essential @EASLNews Marco Carbone Emma Culver

👩‍⚕️ ERCP (endoscopic retrograde cholangiopancreatography) in PSC - when, how and by whom When? - Possible dominant or relevant stricture(s) on MRC - Suspicion on neoplasia - To slow down disease progression (?) How? - Always sample from possible DS - In case of equivocal

A special day for PSC. One phase II (in Journal of Hepatology below, elafibranor) and one phase III (nor-UDCA, presented at the #EASLCongress) trial with potentially positive efficacy signals. Great inspiration. journal-of-hepatology.eu/article/S0168-…

From genetic associations to environmental triggers in PSC. Our EBV-paper is out in Nature Medicine today. nature.com/articles/s4159…